Contents of this document
- Launch of sales of Sanctuary Court Sotobo Suzumejima
- Capital and business alliance with Mitsubishi Corporation for high-value-added healthcare in Asian markets
- Contracts for 2 sites in Kyushu for hotel and other business operations
- Full-scale entry into the home-visit nursing business
- Introduction and expansion of HiMedic Care
- Considering a transition to a real estate ownership model
- Planned opening of 2 regenerative medicine and other clinics in Tokyo and Osaka
- Hotel and medical membership contract value¥733 100 million+6.0%
- Hotel membership-rights contract value¥682 100 million+5.0%
- HIMEDIC contract value¥46 100 million
- Membership21 10,000 people
- App members12 10,000 people
- Number of LINE implementations40 10,000 people
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥123,886 millions (YoY +11.7%) |
| Operating profit | ¥16,304 millions (YoY +31.3%) |
| Ordinary income | ¥16,196 millions (YoY +30.1%) |
| Net income | ¥11,378 millions (YoY +32.0%) |
| Operating profit margin | Approximately 13.2% |
| Full-year earnings forecast | Net Sales ¥259,000 millions / Operating profit ¥32,000 millions / Ordinary income ¥31,500 millions / Net income for the current fiscal year ¥21,600 millions / Adjusted revenue ¥280,000 millions / Adjusted operating profit ¥39,700 millions |
| Self-assessment against the plan | Progress significantly ahead of plan |
| Segment results | Membership Rights Net Sales ¥36,099 millions (YoY +28.8%) / Operating profit ¥13,351 millions (YoY +38.7%) / Hotels and restaurants Net Sales ¥57,662 millions (YoY +4.3%) / Operating profit ¥3,658 millions (YoY +2.9%) / Medical Net Sales ¥29,733 millions (YoY +8.9%) / Operating profit ¥4,864 millions (YoY +22.1%) / Other Net Sales ¥390 millions (YoY +10.6%) / Operating profit ¥374 millions (YoY +10.8%) |
| Breakdown of Factors Affecting the Change | Profit growth across all businesses, including the membership, hotel and restaurant, and medical businesses. Factors included price revisions, higher average prices, increased sales of existing properties, profit growth in each medical business, and the impact of lower hotel occupancy. Detailed amounts are shown in the bridge chart. |
| Key KPIs | Hotel and medical membership contract value ¥733 100 million (YoY +6.0%), Hotel membership-rights contract value ¥682 100 million (YoY +5.0%), HIMEDIC contract value ¥46 100 million, Membership 21 10,000 people, App members 12 10,000 people, Number of LINE implementations 40 10,000 people |
| Unit price and quantity metrics | Membership hotel occupancy rate 56.9 % (YoY -1.5%) / Average spending per member ¥21.3 10,000 (YoY +4.0%) / Facility revenue / number of overnight guests Not disclosed |
| Assumptions Underlying the Business Outlook | Hotel occupancy rate XIV 55.3% / BCC 55.0% / SAC 66.3% / Hotel membership-rights contract value ¥1,260 100 million / HIMEDIC contract value ¥86 100 million / unit_2 ¥100 million / Reduction in realized revenue upon opening ¥-197 100 million / unit_3 ¥100 million |
| Risk amount incorporated into the outlook | Reduction in realized revenue upon opening ¥-197 100 million / Details Lower realized revenue at launch |
| Medium-term management plan targets | Consolidated operating profit ¥50 billion or more in fiscal 2029 / Adjusted operating profit Growth of 10% or more every fiscal year / Increase in membership Hotel: 25,000 units; medical: 15,000 units / ROE Medium- to long-term target of 15% |
| Financial targets | ROE Target Medium- to long-term target of 15% / Actual results 13.7% for the fiscal year ended March 2026 (15.4% based on valuation gains) / DOE Target 5.0% / Lower limit 4.5% / Actual results 4.7% for the fiscal year ended March 2026 |
| Annual Dividend | ¥37 /share |
| Capital expenditures | 2,500 Hundreds of millions of yen (five-year hotel business investment) |
| Market Size / Share | Domestic affluent individuals 1.65 million households / Net financial assets ¥364 trillion / Penetration rate among the company's members Kanto 8% / Chubu 17% / Kansai 16% / Other 2% |
| New initiatives | Launch of sales of Sanctuary Court Sotobo Suzumejima, Capital and business alliance with Mitsubishi Corporation for high-value-added healthcare in Asian markets, Contracts for 2 sites in Kyushu for hotel and other business operations, Full-scale entry into the home-visit nursing business, Introduction and expansion of HiMedic Care, Considering a transition to a real estate ownership model, Planned opening of 2 regenerative medicine and other clinics in Tokyo and Osaka |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.All businesses posted increases in revenue and profit, driven by higher sales contracts for existing properties, the effects of price revisions for memberships and hotels, higher average prices at hotel restaurants, and increases in medical business membership and merchandise sales. Hotel occupancy declined because of typhoons and torrential rain, but the effect of higher average prices contributed to performance.